Form 4 for MAZE Maze Therapeutics, Inc.
Accepted 2026-05-06 16:13:06 ET · period of report 2026-05-04 · accession 0001192591-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 16:13 | 2026-05-04 | MAZE | HOMCY CHARLES J | Dir | G - Gift | $0.00 | -7,422 | 31.1K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-04 | G | D | 7,422 | $0.00 | 31,113 | D | — | — | (F1) The reported transaction represents a gift, for no consideration, which is exempt pursuant to Rule 16b-5. (F2) The total reflected in Column 5 of Table I includes shares which were previously held directly by the Charles J. Homcy Revocable Trust UA 11/4/1998. |